Therefore, albumin paclitaxel combined with platinum‐based chemotherapy and immunotherapy did not increase the major cardiopulmonary and anastomotic complications in patients with locally advanced ESCC, which appeared to be safe and feasible. Here, ALB is linked to esophageal squamous cell carcinoma.